Alpha DNA Investment Management’s Ares Capital ARCC Stock Holding History

Alpha DNA Investment Management’s Portfolio ARCC Stock Details ARCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-56,681	Closed	-$1.04M	–	156
2023 Q1	$1.04M	Buy	56,681 +393	+0.7%	+$7.43K	0.31%	107
2022 Q4	$1.04M	Buy	+56,288	New	+$1.06M	0.37%	116
2022 Q2	–	Sell	-55,777	Closed	-$1.17M	–	121
2022 Q1	$1.17M	Buy	+55,777	New	+$1.19M	0.82%	84

Other funds holding ARCC

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ACM

Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return

Alpha DNA Investment Management's ARCC Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of Ares Capital (ARCC) in Q2 2023, closing a stake of 56,681 shares — an estimated $1.04M sold.

Alpha DNA Investment Management first reported a position in ARCC in Q1 2022 and held it in 3 quarters. The position peaked at $1.17M in Q1 2022. 657 funds tracked by Wall St. Rank hold ARCC as of Q2 2023.

Alpha DNA Investment Management reported no remaining Ares Capital position as of Q2 2023 after selling out during the quarter.
Alpha DNA Investment Management sold 56,681 Ares Capital shares in Q2 2023, an estimated $1.04M.
Alpha DNA Investment Management first reported a position in Ares Capital in Q1 2022 and held it in 3 quarters.
Alpha DNA Investment Management's Ares Capital position peaked at $1.17M in Q1 2022.
657 funds tracked by Wall St. Rank held Ares Capital as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.